Ambrx Trademark Application - Cancer Bio-therapeutics
Summary
USPTO published Ambrx's Intent to Use trademark application (TM90487620) for biological and biochemical preparations used in cancer treatment. The application covers protein expression systems for generating novel bio-therapeutics, including bio-conjugated peptides, therapeutic proteins, monoclonal antibodies, and bi/multi-specific medicines. This Class 005 pharmaceutical trademark was filed on January 25, 2021.
What changed
Ambrx filed an Intent to Use trademark application with the USPTO for cancer treatment preparations comprising protein expression systems (amino acids, enzymes, RNA molecules, live cells). The goods description covers novel bio-therapeutics, bio-conjugated peptides, therapeutic proteins, monoclonal antibodies, and bi/multi-specific medicines under Nice Class 005 (Pharmaceuticals). Application TM90487620 was filed January 25, 2021.
This publication is informational for trademark monitoring purposes. Pharmaceutical companies developing similar therapeutic products should review clearance procedures to avoid potential conflicts. Investors tracking Ambrx's IP portfolio can note this cancer bio-therapeutics trademark filing as part of the company's intellectual property strategy. No immediate compliance action is required from other market participants unless they seek to oppose the registration.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
AMBRX
Intent to Use TM90487620 Kind: intenttouse Apr 02, 2026
Abstract
Biological and biochemical preparations for the treatment of cancer, namely, protein expression systems consisting of amino acids, enzymes, RNA molecules, and live cells for generating novel bio-therapeutics and optimizing the performance of bio-conjugated peptides, therapeutic proteins, monoclonal antibodies, and bi- and multi-specific medicines
Filing Date
2021-01-25
Named provisions
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.